Hackeng T M, Tans G, Koppelman S J, de Groot P G, Rosing J, Bouma B N
Department of Haematology, University Hospital Utrecht, The Netherlands.
Biochem J. 1996 Oct 15;319 ( Pt 2)(Pt 2):399-405. doi: 10.1042/bj3190399.
The conversion of protein C into activated protein C (APC) by the thrombin-thrombomodulin complex on the surface of endothelial cells initiates an essential negative feedback reaction on blood coagulation. APC, together with its non-enzymic cofactor protein S, inactivates factors Va and VIIIa, the non-enzymic protein cofactors of the prothrombinase and intrinsic tenase complex, by proteolytic degradation. In this study we report that prothrombin activation products, generated by the prothrombinase complex on the surface of quiescent endothelial cells, are able to activate protein C. Subsequent inactivation of factor Va by the APC that was formed decreased the rate of prothrombin activation, thus demonstrating in vitro the negative feedback loop on coagulation factor activation. The anticoagulant feedback reaction of APC on the prothrombinase complex was stimulated 3-4-fold by the addition of protein S but not by thrombin-cleaved protein S or by protein S complexed with C4b-binding protein. Stimulation of endothelial cells with 50 pM tumour necrosis factor (TNF) or 500 pM interleukin 1 (IL-1) resulted in a 70% decrease in activation of protein C by exogenously added alpha-thrombin, which seemed to be due to down-regulation of thrombomodulin activity on the surface of endothelial cells. However, when prothrombin activation products generated in situ were allowed to activate protein C, stimulation of endothelial cells with TNF and IL-1 resulted in only a 25% decrease in activation of protein C. Stimulation with TNF or IL-1 did not affect the ability of endothelial cells to support prothrombinase activity. We investigated whether the differences in extent of protein C activation by exogenously added alpha-thrombin and by prothrombin activation products generated in situ were due to meizothrombin formed during prothrombin activation. Previous reports from our groups revealed that meizothrombin is generated as a transient intermediate during prothrombin activation on phospholipid vesicles and endothelial cells. Here we show that meizothrombin is at least a 6-fold better activator of protein C on the surface of endothelial cells than is alpha-thrombin. These results demonstrate that meizothrombin, formed during the initial phase of prothrombin activation, efficiently down-regulates both its own formation and that of thrombin.
在内皮细胞表面,凝血酶 - 血栓调节蛋白复合物将蛋白C转化为活化蛋白C(APC),从而启动对血液凝固至关重要的负反馈反应。APC与其非酶辅因子蛋白S一起,通过蛋白水解降解使因子Va和VIIIa失活,因子Va和VIIIa分别是凝血酶原酶和内源性凝血酶原酶复合物的非酶蛋白辅因子。在本研究中,我们报告称,在静止内皮细胞表面由凝血酶原酶复合物产生的凝血酶原激活产物能够激活蛋白C。随后形成的APC使因子Va失活,从而降低了凝血酶原激活的速率,由此在体外证明了凝血因子激活中的负反馈环。通过添加蛋白S,APC对凝血酶原酶复合物的抗凝反馈反应增强了3 - 4倍,但凝血酶裂解的蛋白S或与C4b结合蛋白复合的蛋白S则无此作用。用50 pM肿瘤坏死因子(TNF)或500 pM白细胞介素1(IL - 1)刺激内皮细胞,导致外源性添加的α-凝血酶对蛋白C的激活作用降低70%,这似乎是由于内皮细胞表面血栓调节蛋白活性下调所致。然而,当原位产生的凝血酶原激活产物激活蛋白C时,用TNF和IL - 1刺激内皮细胞仅导致蛋白C激活降低25%。用TNF或IL - 1刺激并不影响内皮细胞支持凝血酶原酶活性的能力。我们研究了外源性添加的α-凝血酶和原位产生的凝血酶原激活产物对蛋白C激活程度的差异是否归因于凝血酶原激活过程中形成的中间凝血酶。我们团队之前的报告显示,在磷脂囊泡和内皮细胞上凝血酶原激活过程中,中间凝血酶作为一种瞬时中间体产生。在此我们表明,在内皮细胞表面,中间凝血酶激活蛋白C的能力至少是α-凝血酶的6倍。这些结果表明,在凝血酶原激活初始阶段形成的中间凝血酶能有效下调其自身及凝血酶的形成。